Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD51 | Q06609 | 1/20 | 0.43 |
| ▸ | RIPK1 | Q13546 | 17/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30175846 | 0.84 | RAD51 (0.46) | RAD51RIPK1 | |
| SCHEMBL30175855 | 0.73 | RIPK1 (0.54) | RIPK1 | |
| SCHEMBL30175857 | 0.73 | RIPK1 (0.54) | RIPK1ACHE | |
| SCHEMBL30175812 | 0.73 | RIPK1 (0.72) | RIPK1 | |
| SCHEMBL24351038 | 0.72 | RIPK1 (0.70) | RIPK1 | |
| SCHEMBL30175816 | 0.70 | RIPK1 (0.77) | RIPK1 | |
| SCHEMBL30175827 | 0.70 | RAB9A (0.55) | RIPK1 | |
| SCHEMBL30701109 | 0.67 | PRKCI (0.52) | — | |
| SCHEMBL3133961 | 0.67 | PRKCI (0.52) | — | |
| SCHEMBL23808154 | 0.67 | NPC1 (0.52) | RIPK1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230052747-A1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF TUMORS | TES PHARMA S.R.L. (IT) | 2023-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230052747-A1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF TUMORS | RAD51, BRCA1, FANCI | RAD51 1/4885RIPK1 3215/4885ACHE 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.